Notificação de entrada na fase nacional - PCT
#1.3
11/26/2024
RPI 2812
Application data
Number
112024016378Type
Filing
Publication
PCT
US2023062351 The application was filed at the INPI on 02/10/2023. It awaits formal examination and publication in the RPI gazette.
Latest action published by the INPI: 11/26/2024. We update with every new RPI gazette, published weekly.
Applicants
MADRIGAL PHARMACEUTICALS, INC.
US
Inventors
J. H. (pessoa física)
US
P. C. (pessoa física)
US
IPC Classification
Priority claims
US
63/308,709 · 02/10/2022
US
63/419,790 · 10/27/2022
Abstract
ANÁLOGOS DE THR BETA E USOS DOS MESMOS. A presente invenção refere-se a compostos de fórmula I e sais, solvatos, e estereoisômeros farmaceuticamente aceitáveis dos mesmos, e seus usos como ativadores do receptor de hormônio da tireoide (THR) ß.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
11/26/2024
RPI 2812
#1.1
08/20/2024
RPI 2798
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.